C J Diskin

Summary

Affiliation: Kathleen D. Schaum and Associates
Country: USA

Publications

  1. ncbi Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?
    Charles J Diskin
    HNDT, Auburn University, Opelika, AL 36801, USA
    Kidney Blood Press Res 29:54-9. 2006
  2. ncbi Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA
    J Nephrol 20:410-6. 2007
  3. ncbi Beyond anemia: the clinical impact of the physiologic effects of erythropoietin
    Charles J Diskin
    Department of Hypertension, Nephrology, Dialysis and Transplantation, Auburn University, Opelika, Alabama 36801, USA
    Semin Dial 21:447-54. 2008
  4. ncbi Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease
    Charles J Diskin
    HNDT, Auburn University, Opelika, Alabama 36801, USA
    Am J Med Sci 332:156-8. 2006
  5. ncbi Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, Alabama 36801, USA
    Nephrology (Carlton) 11:394-9. 2006
  6. ncbi Acute renal failure due to a primary renal B-cell lymphoma
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University
    Am J Kidney Dis 50:885-9. 2007
  7. ncbi Gustatory sweating recurring on peritoneal dialysis but resolving during periods of hemodialysis
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, Alabama 36801, USA
    Hemodial Int 12:230-2. 2008
  8. ncbi Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement
    Charles J Diskin
    Department of Hypertension, Nephrology, Dialysis, Transplantation, Auburn University, Opelika, AL 36801, USA
    Int Urol Nephrol 39:599-602. 2007
  9. ncbi Creatinine and glomerular filtration rate: evolution of an accommodation
    Charles J Diskin
    Hypertension, Nephrology, Dialysis, and Transplantation Clinic, Auburn University, Building 21, 121 N 20th Street, Opelika, AL 36801, USA
    Ann Clin Biochem 44:16-9. 2007
  10. ncbi Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors
    Charles J Diskin
    Auburn University, Opelika, Ala 36801, USA
    Nephron Clin Pract 107:c128-32. 2007

Detail Information

Publications49

  1. ncbi Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?
    Charles J Diskin
    HNDT, Auburn University, Opelika, AL 36801, USA
    Kidney Blood Press Res 29:54-9. 2006
    ....
  2. ncbi Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA
    J Nephrol 20:410-6. 2007
    ....
  3. ncbi Beyond anemia: the clinical impact of the physiologic effects of erythropoietin
    Charles J Diskin
    Department of Hypertension, Nephrology, Dialysis and Transplantation, Auburn University, Opelika, Alabama 36801, USA
    Semin Dial 21:447-54. 2008
    ..We will review what is known about the physiology of this plasma factor that, it is now clear, is more than just an erythrocyte production factor...
  4. ncbi Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease
    Charles J Diskin
    HNDT, Auburn University, Opelika, Alabama 36801, USA
    Am J Med Sci 332:156-8. 2006
    ..Measurements of total methotrexate levels were made before, during, and after sequential peritoneal and hemodialysis treatments...
  5. ncbi Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, Alabama 36801, USA
    Nephrology (Carlton) 11:394-9. 2006
    ....
  6. ncbi Acute renal failure due to a primary renal B-cell lymphoma
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University
    Am J Kidney Dis 50:885-9. 2007
  7. ncbi Gustatory sweating recurring on peritoneal dialysis but resolving during periods of hemodialysis
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, Alabama 36801, USA
    Hemodial Int 12:230-2. 2008
    ..Treatment with topical glycopyrrolate may be safe and effective given every third day if clonidine is ineffective...
  8. ncbi Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement
    Charles J Diskin
    Department of Hypertension, Nephrology, Dialysis, Transplantation, Auburn University, Opelika, AL 36801, USA
    Int Urol Nephrol 39:599-602. 2007
    ....
  9. ncbi Creatinine and glomerular filtration rate: evolution of an accommodation
    Charles J Diskin
    Hypertension, Nephrology, Dialysis, and Transplantation Clinic, Auburn University, Building 21, 121 N 20th Street, Opelika, AL 36801, USA
    Ann Clin Biochem 44:16-9. 2007
    ....
  10. ncbi Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors
    Charles J Diskin
    Auburn University, Opelika, Ala 36801, USA
    Nephron Clin Pract 107:c128-32. 2007
    ..Intravenous iron and heparin are thought to promote the formation of biofilm. Both are commonly employed during hemodialysis treatments which might affect the incidence of catheter-related sepsis...
  11. ncbi The role of the nephrologist in the treatment of lupus nephritis
    Charles J Diskin
    Hypertension, Nephrology, Dialysis, and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA
    Nat Clin Pract Nephrol 3:E1. 2007
  12. ncbi Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin
    Charles J Diskin
    Auburn University, Opelika, AL 36801, USA
    Clin Lung Cancer 8:434-5. 2007
    ..Intravenous calcitonin produced a dramatic decrease within 12 hours and normal serum calcium within 24 hours of treatment. Calcitonin might be useful for hypercalcemia of malignancy resistant to bisphosphonates...
  13. ncbi Recurrent metabolic alkalosis and elevated troponins after crack cocaine use in a hemodialysis patient
    Charles J Diskin
    HNDT, Auburn University, Bldg 21, 121 N 20th Street, Opelika, AL 36801, USA
    Clin Exp Nephrol 10:156-8. 2006
    ..The metabolic alkalosis did not recur after counseling and abstention from cocaine...
  14. ncbi Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA
    Nat Clin Pract Nephrol 4:628-38. 2008
    ..Currently available drugs that interfere with metalloproteinases could prevent the formation of aneurysms, and bacterial quorum sensing offers a promising target for the prevention of biofilm infection in hemodialysis catheters...
  15. ncbi The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service
    Charles J Diskin
    Department of Hypertension, Nephrology, Dialysis and Transplantation, Auburn University, Opelika, AL 36801, USA
    Nephrol Dial Transplant 26:2549-58. 2011
    ....
  16. ncbi Observe and be guarded: the development and rupture of an abdominal aortic mycotic aneurysm in an afebrile hemodialysis patient with normal angiogram, and CT scan, and sterile blood cultures
    Charles J Diskin
    Auburn University Hypertension, Nephrology, 122 N 20th Street, Opelika, AL 36802, USA
    Clin Exp Nephrol 8:388-91. 2004
    ..After a discussion of pathophysiology, we offer some insight into why so few mycotic aneurysms are reported in the hemodialysis population...
  17. ncbi Toward the optimal clinical use of the fraction excretion of solutes in oliguric azotemia
    Charles J Diskin
    Hypertension, Nephrology, Dialysis, and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA
    Ren Fail 32:1245-54. 2010
    ..We review the tubular physiology of these solutes and show how the differences in tubular physiology might be exploited to develop a strategy for their optimal clinical use...
  18. ncbi The use of new concepts in vascular physiology and pharmacology to improve hemodialysis access outcomes
    C J Diskin
    Departments of Hypertention, Nephrology, Dialysis and Transplantion, Auburn University, Opelika, AL 36801, USA
    Minerva Urol Nefrol 62:387-410. 2010
    ..Large prospective randomized studies will be needed to determine the true benefit...
  19. ncbi Can the combination of calcium and parathormone levels above K/DOQI guidelines be used as a marker of adynamic bone disease in African Americans?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Bldg 21, 121 N 20th Street, Opelika, AL 36801, USA
    Int Urol Nephrol 43:1127-32. 2011
    ..Calcium levels above K/DOQI guidelines therefore may signal a need to stop parathyroid suppression...
  20. ncbi Novel insights into the pathobiology of the vascular access - do they translate into improved care?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation, Auburn University, Opelika, Ala, USA
    Blood Purif 29:216-29. 2010
    ..Implications for possible future interventions based on these novel concepts are offered, and the significance of improving our understanding of the pathobiology is emphasized...
  21. ncbi Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: is a natriuretic peptide activated?
    Charles Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, AL 36801, USA
    Am J Med Sci 331:37-9. 2006
    ..We speculate that a central nervous system natriuretic peptide may be involved in the pathogenesis of the naturesis following intrathecal methotrexate...
  22. ncbi Lessons from single cell organisms: insights into the antimicrobial and toxic effects of peritoneal dialysate bases
    Charles J Diskin
    Department of Hypertension, Nephrology, Dialysis and Transplantation, Auburn University, Opelika, AL 36801, USA
    Ther Apher Dial 14:127-35. 2010
    ..While our knowledge base in this area is still evolving, an improved understanding of the biochemical basis of both the antibacterial effect and toxicity of the salts of carboxylic acids in peritoneal dialysate can only prove useful...
  23. ncbi Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation, Auburn University, Opelika, Alabama 36801, USA
    J Nephrol 23:438-43. 2010
    ..We chose to investigate whether the use of omeprazole could reduce the incidence of hypercalcemia in dialysis patients who could not afford expensive non-calciumbased phosphate binders...
  24. ncbi de Ketham revisited: a modern-day urine wheel
    Charles J Diskin
    Hypertension, Nephrology, Dialysis and Transplantation Clinic, Auburn University, Opelika, Ala, USA
    Med J Aust 189:658-9. 2008
    ..In honour of de Ketham, a modern urine wheel is presented, which may be a useful diagnostic tool for present-day physicians...
  25. ncbi A hypothesis: can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure?
    Charles J Diskin
    Auburn University, 2609 Village Professional Drive, Opelika, AL 36801, USA
    Am J Med Sci 334:260-4. 2007
    ..Therefore, we chose to examine whether severity and progression of diabetic retinopathy has been accelerated by the administration of recombinant erythropoietin to patients with chronic renal failure...
  26. ncbi Massive increase in proteinuria after the introduction of midodrine in an elderly patient-a case report
    Charles J Diskin
    HNDT, Auburn University, Opelika, AL 36801, USA
    Nephrol Dial Transplant 21:1988. 2006
  27. ncbi Minoxidil use in proteinuric renal disease
    Charles J Diskin
    Acta Med Croatica 62:93. 2008
  28. ncbi More on case 7-2006
    Charles J Diskin
    N Engl J Med 355:1502-3; author reply 1503. 2006
  29. ncbi Heparin and biofilm: is this the risk factor for catheter-related sepsis?
    Charles J Diskin
    Am J Kidney Dis 52:197-8; author reply 198. 2008
  30. ncbi Hemoglobin targets versus oxygen delivery: is it time for a new paradigm?
    Charles J Diskin
    Blood Purif 25:280; author reply 280. 2007
  31. ncbi Erythropoietin levels and androgens use: what is their relationship in the correction of anemia?
    Charles J Diskin
    Arch Intern Med 167:309. 2007
  32. ncbi The contribution of nutrition to the protective value of high plasma aldosterone concentrations in hemodialysis patients
    Charles J Diskin
    Hypertens Res 30:751-2; author reply 752-4. 2007
  33. ncbi Multiple mechanisms for abnormal selenium levels and vascular disease in renal failure
    Charles J Diskin
    Am J Kidney Dis 47:924; author reply 924-5. 2006
  34. ncbi Notes on angiotensin inhibition and vascular access survival: time for randomized controlled trials
    Charles J Diskin
    Nephrol Dial Transplant 21:823; author reply 824. 2006
  35. ncbi R wave increases after hemodialysis revisited
    Charles J Diskin
    Ann Noninvasive Electrocardiol 11:198-9. 2006
  36. ncbi A change of reason: medicine and the scientific revolution
    Charles J Diskin
    Arch Intern Med 166:369-70; author reply 370. 2006
  37. ncbi Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal disease after a quarter of century
    Charles J Diskin
    Nephrol Dial Transplant 21:1739. 2006
  38. ncbi Vascular access cannulation and the end of religion: is it time or our own human variables that determine success?
    Charles J Diskin
    Nephrol Dial Transplant 20:2010-1; author reply 2011. 2005
  39. ncbi Pharmacologic intervention to prevent hemodialysis vascular access thrombosis: the next generation of treatment?
    Charles J Diskin
    Kidney Int 67:2505. 2005
  40. ncbi The clinical significance of aldosterone in ESRD: Part II
    Charles J Diskin
    Nephrol Dial Transplant 19:1331-2; author reply 1332. 2004
  41. ncbi Creatinine and GFR: an imperfect marriage of convenience
    Charles J Diskin
    Nephrol Dial Transplant 21:3338-9. 2006
  42. ncbi Electrocardiographic R wave increases after hemodialysis: round III
    Charles J Diskin
    Saudi J Kidney Dis Transpl 19:648-50; author reply 650. 2008
  43. ncbi Peritoneal dialysis in patients with liver cirrhosis and/or ascites
    Charles J Diskin
    Wien Klin Wochenschr 118:435; author reply 435-6. 2006
  44. ncbi Is it time to reexamine KDOQI aluminum guidelines?
    Charles J Diskin
    Am J Kidney Dis 48:876-7. 2006
  45. ncbi Heparin, biofilm, and catheter-related sepsis
    Charles J Diskin
    Diagn Microbiol Infect Dis 61:80; author reply 80-81. 2008
  46. ncbi Is the timing of thallium injection in relation to hemodialysis treatments important?
    Charles J Diskin
    Ther Apher Dial 11:241; author reply 242. 2007
  47. ncbi An understanding of trace metal physiology as an aid to interpretation of clearance studies by artificial organs
    Charles J Diskin
    Nephrol Dial Transplant 23:1462; author reply 1462-3. 2008
  48. ncbi Hitting the target but missing the goal? Hemoglobin targets versus oxygen delivery
    Charles J Diskin
    Am J Kidney Dis 50:344; author reply 344. 2007
  49. ncbi Analgesic use in hemodialysis patients: Osler at the bedside and computer-generated data
    Charles J Diskin
    Kidney Int 67:378-9; author reply 379. 2005